All Stories

  1. Promising biomarkers for mild cognitive impairment and Alzheimer’s disease: Levels of soluble endothelial glycocalyx products

    Article • Neural Regeneration Research, January 2026, Wolters Kluwer Health

    Roberto Monastero, Prof Carmela Rita Balistreri

  2. Transcranial Random Noise Stimulation over the Dorsolateral Prefrontal Cortex in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Pilot Study

    Article • Brain Sciences, November 2025, MDPI AG

    Roberto Monastero

  3. Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review

    Article • Deutsche Zeitschrift für Nervenheilkunde, May 2025, Springer Science + Business Media

    Roberto Monastero, Prof Carmela Rita Balistreri

  4. TREM 2 in Parkinson’s Disease: A Promising Candidate Gene for Disease Susceptibility and Progression

    Article • Brain Sciences, April 2025, MDPI AG

    Roberto Monastero, Prof Carmela Rita Balistreri

  5. Telecoaching and Migraine: Digital Approach to Physical Activity in Migraine Management. A Scoping Review

    Article • Journal of Clinical Medicine, January 2025, MDPI AG

    Roberto Monastero

  6. The Impact of COVID-19 on Migraine: The Patients’ Perspective

    Article • Life, November 2024, MDPI AG

    Roberto Monastero

  7. Syndecans in Alzheimer’s disease: pathogenetic mechanisms and potential therapeutic targets

    Article • Neural Regeneration Research, September 2024, Wolters Kluwer Health

    Prof Carmela Rita Balistreri, Roberto Monastero

  8. Effectiveness and Safety of Mycophenolate Mophetil in Myasthenia Gravis: A Real-Life Multicenter Experience

    Article • Brain Sciences, July 2024, MDPI AG

    Roberto Monastero

  9. Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?

    Article • Brain Sciences, December 2023, MDPI AG

    Prof Carmela Rita Balistreri, Roberto Monastero

  10. Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?

    Article • November 2023, MDPI AG

    Prof Carmela Rita Balistreri, Roberto Monastero

  11. Persistent Cognitive Dysfunction in a Non-Hospitalized COVID-19 Long-Hauler Patient Responding to Cognitive Rehabilitation and Citicoline Treatment

    Article • Brain Sciences, September 2023, MDPI AG

    Roberto Monastero

  12. Sex and gender differences in Alzheimer’s disease, Parkinson’s disease, and Amyotrophic Lateral Sclerosis: A narrative review

    Article • Mechanisms of Ageing and Development, June 2023, Elsevier

    Roberto Monastero

  13. Internal carotid artery dissection in a patient with hemophilia A: a case report and literature review

    Article • Neurological Sciences, February 2023, Springer Science + Business Media

    Roberto Monastero

  14. Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis

    Article • Brain Sciences, January 2023, MDPI AG

    Roberto Monastero

  15. Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis

    Article • Brain Sciences, October 2022, MDPI AG

    Prof Carmela Rita Balistreri, Roberto Monastero

  16. Sound-Induced Flash Illusions Support Cortex Hyperexcitability in Fibromyalgia

    Article • Pain Research and Management, September 2022, Wiley

    Roberto Monastero

  17. From Small Peptides to Large Proteins against Alzheimer’sDisease

    Article • Biomolecules, September 2022, MDPI AG

    Roberto Monastero

  18. Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis

    Article • September 2022, MDPI AG

    Prof Carmela Rita Balistreri, Roberto Monastero

  19. Hands–feet wireless devices: Test–retest reliability and discriminant validity of motor measures in Parkinson's disease telemonitoring

    Article • Acta Neurologica Scandinavica, July 2022, Wiley

    Roberto Monastero

  20. Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabút Aging Project

    Article • Journal of Alzheimer’s Disease, May 2022, IOS Press

    Roberto Monastero

  21. Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabùt Aging Project

    Article • Journal of Alzheimer’s Disease, May 2022, IOS Press

    Roberto Monastero

  22. Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study

    Article • Acta Neurovegetativa, January 2022, Springer Science + Business Media

    Roberto Monastero

  23. Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review

    Article • Brain Sciences, June 2021, MDPI AG

    Roberto Monastero

  24. Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort

    Article • Scientific Reports, January 2021, Springer Science + Business Media

    Roberto Monastero

  25. Transcranial random noise stimulation over the primary motor cortex in PD-MCI patients: a crossover, randomized, sham-controlled study

    Article • Acta Neurovegetativa, September 2020, Springer Science + Business Media

    Roberto Monastero

  26. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study

    Article • Deutsche Zeitschrift für Nervenheilkunde, August 2020, Springer Science + Business Media

    Roberto Monastero

  27. Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 project

    Article • Aging Clinical and Experimental Research, May 2020, Springer Science + Business Media

    Roberto Monastero

  28. Cardiovascular autonomic function and MCI in Parkinson's disease

    Article • Parkinsonism & Related Disorders, December 2019, Elsevier

    Roberto Monastero

  29. Electrocortical networks in Parkinson's disease patients with Mild Cognitive Impairment. The PaCoS study

    Article • Parkinsonism & Related Disorders, July 2019, Elsevier

    Roberto Monastero

  30. Objective assessment of blinking and facial expressions in Parkinson’s disease using a vertical electro-oculogram and facial surface electromyography

    Article • Physiological Measurement, July 2019, Institute of Physics Publishing

    Roberto Monastero

  31. Visuospatial learning is fostered in migraine: evidence by a neuropsychological study

    Article • Neurological Sciences, June 2019, Springer Science + Business Media

    Roberto Monastero

  32. Mild Behavioral Impairment in Parkinson’s Disease: Data from the Parkinson’s Disease Cognitive Impairment Study (PACOS)

    Article • Journal of Alzheimer’s Disease, April 2019, IOS Press

    Roberto Monastero

  33. Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study

    Article • Frontiers in Aging Neuroscience, February 2019, Frontiers

    Roberto Monastero

  34. Comment on “Sleep disturbances and later cognitive status: a multi-centre study”

    Article • Annals of Translational Medicine, December 2018, AME Publishing Company

    Roberto Monastero

  35. The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI)

    Article • Aging Clinical and Experimental Research, September 2018, Springer Science + Business Media

    Roberto Monastero

  36. Frequency and Correlates of Subjective Memory Complaints in Parkinson’s Disease with and without Mild Cognitive Impairment: Data from the Parkinson’s Disease Cognitive Impairment Study

    Article • Journal of Alzheimer’s Disease, May 2018, IOS Press

    Roberto Monastero

  37. Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)

    Article • Deutsche Zeitschrift für Nervenheilkunde, February 2018, Springer Science + Business Media

    Roberto Monastero

  38. Dietary Supplements as Surrogate of Mediterranean Diet in Healthy Smoking Subjects

    Article • Rejuvenation Research, February 2018, Mary Ann Liebert Inc

    Roberto Monastero

  39. Ageing: from inflammation to cancer

    Article • Immunity & Ageing, January 2018, Springer Science + Business Media

    Roberto Monastero

  40. Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred

    Article • Journal of Clinical Lipidology, January 2018, Elsevier

    Roberto Monastero

  41. The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design

    Article • Neurological Sciences, September 2016, Springer Science + Business Media

    MD MARIA SOFIA COTELLI, Roberto Monastero

  42. β-glucans: ex vivo inflammatory and oxidative stress results after pasta intake

    Article • Immunity & Ageing, April 2016, Springer Science + Business Media

    Roberto Monastero

  43. FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease

    Article • Analytical and Bioanalytical Chemistry, January 2016, Springer Science + Business Media

    Roberto Monastero

  44. Isolated, subtle, neurological abnormalities in neurologically and cognitively healthy aging subjects

    Article • Deutsche Zeitschrift für Nervenheilkunde, April 2015, Springer Science + Business Media

    Dr Cesare Gagliardo, Roberto Monastero

  45. Double Negative (IgG+IgD−CD27−) B Cells are Increased in a Cohort of Moderate-Severe Alzheimer's Disease Patients and Show a Pro-Inflammatory Trafficking Receptor Phenotype

    Article • Journal of Alzheimer’s Disease, February 2015, IOS Press

    Roberto Monastero

  46. Lymphocytic Mitochondrial Aconitase Activity is Reduced in Alzheimer's Disease and Mild Cognitive Impairment

    Article • Journal of Alzheimer’s Disease, January 2015, IOS Press

    Roberto Monastero

  47. Alzheimer’s disease and infections, where we stand and where we go

    Article • Immunity & Ageing, December 2014, Springer Science + Business Media

    Roberto Monastero

  48. Double negative (CD19+IgG+IgD−CD27−) B lymphocytes: A new insight from telomerase in healthy elderly, in centenarian offspring and in Alzheimer's disease patients

    Article • Immunology Letters, November 2014, Elsevier

    Roberto Monastero, Prof Carmela Rita Balistreri

  49. SHIP2: A “NEW” Insulin Pathway Target for Aging Research

    Article • Rejuvenation Research, April 2014, Mary Ann Liebert Inc

    Roberto Monastero, Prof Carmela Rita Balistreri

  50. The neuropsychiatric profile of Parkinson’s disease subjects with and without mild cognitive impairment

    Article • Acta Neurovegetativa, February 2013, Springer Science + Business Media

    Roberto Monastero

  51. Can Alzheimer Disease Be a Form of Type 3 Diabetes?

    Article • Rejuvenation Research, April 2012, Mary Ann Liebert Inc

    Roberto Monastero

  52. Mediterranean Diet and Longevity in Sicily: Survey in a Sicani Mountains Population

    Article • Rejuvenation Research, April 2012, Mary Ann Liebert Inc

    Roberto Monastero

  53. Prevalence and Profile of Mild Cognitive Impairment in Parkinson’s Disease

    Article • Neurodegenerative Diseases, January 2012, Karger Publishers

    Roberto Monastero

  54. Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily

    Article • Biogerontology, July 2011, Springer Science + Business Media

    Roberto Monastero

  55. The symptom of low mood in the prodromal stage of mild cognitive impairment and dementia: a cohort study of a community dwelling elderly population

    Article • Journal of Neurology Neurosurgery & Psychiatry, January 2011, BMJ

    Roberto Monastero

  56. Validation Study of the Italian Addenbrooke’s Cognitive Examination Revised in a Young-Old and Old-Old Population

    Article • Dementia and Geriatric Cognitive Disorders, January 2011, Karger Publishers

    Roberto Monastero

  57. Cognitive Performance in Elderly Patients Undergoing Carotid Endarterectomy or Carotid Artery Stenting: A Twelve-Month Follow-Up Study

    Article • Cerebrovascular Diseases, January 2010, Karger Publishers

    Roberto Monastero

  58. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment

    Article • Ageing Research Reviews, October 2009, Elsevier

    Roberto Monastero

  59. A Systematic Review of Neuropsychiatric Symptoms in Mild Cognitive Impairment

    Article • Journal of Alzheimer’s Disease, July 2009, IOS Press

    Roberto Monastero

  60. Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types

    Article • Acta Psychiatrica Scandinavica, June 2008, Wiley

    Roberto Monastero

  61. Association between plasma lipid levels and migraine in subjects aged ≥50 years: preliminary data from the Zabùt Aging Project

    Article • Neurological Sciences, May 2008, Springer Science + Business Media

    Roberto Monastero

  62. Comorbidity between depressive symptoms and migraine: preliminary data from the Zabút Aging Project

    Article • Neurological Sciences, May 2008, Springer Science + Business Media

    Roberto Monastero

  63. Occurrence of cognitive impairment and dementia in the community: A 9-year-long prospective study

    Article • Neurology, January 2008, Wolters Kluwer Health

    Roberto Monastero

  64. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: Two case reports

    Article • Clinical Neurology and Neurosurgery, January 2008, Elsevier

    Roberto Monastero

  65. Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project

    Article • International Journal of Geriatric Psychiatry, January 2008, Wiley

    Roberto Monastero

  66. Migraine Mediates the Influence of C677T MTHFR Genotypes on Ischemic Stroke Risk With a Stroke-Subtype Effect

    Article • Stroke, December 2007, Wolters Kluwer Health

    Roberto Monastero

  67. Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease

    Article • Clinical Therapeutics, December 2007, Elsevier

    Roberto Monastero

  68. Interictal Executive Dysfunction in Migraineurs Without Aura: Relationship With Duration and Intensity of Attacks

    Article • Cephalalgia, October 2007, SAGE Publications

    Roberto Monastero

  69. Predictors of progression from mild cognitive impairment to Alzheimer disease

    Article • Neurology, May 2007, Wolters Kluwer Health

    Roberto Monastero

  70. Heterogeneity in Risk Factors for Cognitive Impairment, No Dementia: Population-Based Longitudinal Study From the Kungsholmen Project

    Article • American Journal of Geriatric Psychiatry, January 2007, Elsevier

    Roberto Monastero

  71. Vascular Risk Factors in Mild Cognitive Impairment Subtypes

    Article • Dementia and Geriatric Cognitive Disorders, January 2007, Karger Publishers

    Roberto Monastero

  72. Prognosis of migraine headaches in adolescents: A 10-year follow-up study

    Article • Neurology, October 2006, Wolters Kluwer Health

    Roberto Monastero

  73. Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases

    Article • Journal of Neurology Neurosurgery & Psychiatry, October 2006, BMJ

    Roberto Monastero

  74. Association between apolipoprotein E e4 allele and apathy in probable Alzheimer's disease.

    Article • Acta Psychiatrica Scandinavica, January 2006, Wiley

    Roberto Monastero

  75. Erratum

    Article • Acta Psychiatrica Scandinavica, December 2005, Wiley

    Roberto Monastero

  76. Effects of levodopa oral bolus on the kinematics of the pointing movements in Parkinson’s disease patients

    Article • Deutsche Zeitschrift für Nervenheilkunde, April 2005, Springer Science + Business Media

    Roberto Monastero

  77. Cognitive impairment in Behçet's disease patients without overt neurological involvement

    Article • Journal of the Neurological Sciences, May 2004, Elsevier

    Roberto Monastero

  78. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction

    Article • Clinical and Experimental Medicine, November 2003, Springer Science + Business Media

    Roberto Monastero

  79. Corrigendum to “Effects of 8-OH-DPAT on open field performance of young and aged rats prenatally exposed to diazepam: a tool to reveal 5-HT1A receptor function”

    Article • European Neuropsychopharmacology, October 2003, Elsevier

    Roberto Monastero

  80. [3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions

    Article • Neurochemistry International, July 2003, Elsevier

    Roberto Monastero

  81. Effects of 8-OH-DPAT on open field performance of young and aged rats prenatally exposed to diazepam: a tool to reveal 5-HT1A receptor function

    Article • European Neuropsychopharmacology, May 2003, Elsevier

    Roberto Monastero

  82. No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease

    Article • Neuroscience Letters, May 2003, Elsevier

    Roberto Monastero

  83. Prevalence of headache in patients with Behcet's disease without overt neurological involvement

    Article • Cephalalgia, March 2003, SAGE Publications

    Roberto Monastero

  84. Enalapril Prophylaxis for Migraine With Aura

    Article • Headache The Journal of Head and Face Pain, February 2003, Wiley

    Roberto Monastero

  85. Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease

    Article • Neuroscience Letters, December 2002, Elsevier

    Roberto Monastero

  86. Migraine Headaches in Adolescents: A Five-Year Follow-Up Study

    Article • Headache The Journal of Head and Face Pain, November 2002, Wiley

    Roberto Monastero

  87. Red Ear Syndrome and Migraine: Report of Eight Cases

    Article • Headache The Journal of Head and Face Pain, February 2002, Wiley

    Roberto Monastero

  88. Erythematous maculopapular eruption due to rivastigmine therapy

    Article • The American Journal of Medicine, November 2001, Elsevier

    Roberto Monastero

  89. Intracerebral haemorrhage associated with sildenafil citrate

    Article • Deutsche Zeitschrift für Nervenheilkunde, February 2001, Springer Science + Business Media

    Roberto Monastero

  90. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations

    Article • Journal of the Neurological Sciences, February 2001, Elsevier

    Roberto Monastero

  91. Cognitive deficits in beta-thalassemia major

    Article • Acta Neurologica Scandinavica, September 2000, Wiley

    Roberto Monastero